Preview

Cancer Urology

Advanced search

Tulium laser in urothelial carcinoma of the bladder with spread to the ostium of the ureter

https://doi.org/10.17650/1726-9776-2020-16-3-198-204

Abstract

Urothelial transitional cell cancer in developed countries is the 4th most common. In terms of frequency, it is outstripped only by prostate, breast, lung, and colorectal cancer. In the vast majority of cases, urothelial carcinoma develops in the bladder. It accounts for 90—95 % of all cases of transitional cell cancer of the urinary tract. Much less often, in 5—10 % have to deal with its localization in the upper urinary tract (in the calico-pelvic system or ureter). In 17 % of upper urinary tract cancers, bladder cancer is simultaneously diagnosed. The incidence of urothelial transitional cell cancer has increased over the past few decades as a result of improved diagnosis and improved survival of patients with this nosology. The use of modern, high-tech equipment for visualization and direct surgical intervention contributes to such results. The use of laser energy as the main tool for tissue dissection in endoscopic oncourology reveals the undeniable advantages of this method in comparison with the traditional electrosurgery.
We present a clinical observation of the diagnosis and surgical treatment of urothelial bladder cancer with invasion of the ureter, performed by en-bloc tulium laser. An operation was performed-transurethral resection of a urothelial bladder tumor with invasion of the ureter, performed by en-bloc tulium laser. Intraoperatively, ureteropieloscopy was performed, and the tumor did not spread to the upper urinary tract beyond the intramural part of the ureter. Thanks to the precision of the action of the tulium laser on the tissue, not resection, but, in fact, dissection of the bladder wall, a high-quality macropreparation was obtained, which made it possible to establish a final diagnosis. Histological conclusion: from the bladder — non-invasive urothelial cancer G2-3; from the mouth of the left ureter — fragments of fibrous tissue lined with urothelium from atypia. 3 months after the operation — no recurrence of urothelial cancer was revealed, which indicates a high quality of the operation.
This clinical observation demonstrates the superiority of laser en-bloc dissection compared to the treatment of bladder tumors. Obtaining a macro-product of urothelial transitional cell cancer of the highest quality can contribute to avoiding unjustified radical nephrureterectomies and conducting organ-preserving treatment, for absolute and elective indications. The 1.94 µm Tulium Erbium laser is an effective tool for performing minimally invasive transurethral interventions in non-invasive bladder cancer.

About the Authors

M. E. Novikov
Group of companies “Medsi”, Clinical Hospital No. 1 “Medsi”
Russian Federation
Build. 1A, possession 2, 6th km Pyatnitskoe Shosse, Otradnoe, Moscow region 143442.
Competing Interests: The authors declare no conflict of interest.


N. A. Meleshko
Group of companies “Medsi”, Clinical Hospital No. 1 “Medsi”
Russian Federation
Build. 1A, possession 2, 6th km Pyatnitskoe Shosse, Otradnoe, Moscow region 143442.
Competing Interests: The authors declare no conflict of interest.


I. G. Akopyan
Group of companies “Medsi”, Clinical Hospital No. 1 “Medsi”
Russian Federation
Build. 1A, possession 2, 6th km Pyatnitskoe Shosse, Otradnoe, Moscow region 143442.
Competing Interests: The authors declare no conflict of interest.


References

1. Siegel R.L., Miller K.D., Jemal A. Cancer statistics, 2017. CA Cancer J Clin 2017;67 (1):7-30. DOI: 10.3322/caac.21387.

2. Babjuk M. EAU Guidelines on Non-muscle-invasive Bladder Cancer (Ta, T1 and CIS). In EAU Guidelines. Edn. Presented at the 34th EAU Annual Congress Barcelona, 2019, EAU Guidelines Office.

3. Munoz J.J., Ellison L.M. Upper tract urothelial neoplasms: incidence and survival during the last 2 decades. J Urol 2000; 164(5):1523-5.

4. Cosentino M., Palou J., Gaya J.M. et al. Upper urinary tract urothelial cell carcinoma: location as a predictive factor for concomitant bladder carcinoma. World J Urol 2013;31 (1):141-5. DOI: 10.1007/s00345-012-0877-2.

5. Izquierdo L., Truan D., Alvarez-Vijande R., Alcaraz A. Large series of 114 cases with long term follow-up of upper urinary tract urothelial tumors. Actas Urol Esp 2010;34 (3):232-7. DOI: 10.1016/j.acuro.2009.11.004.

6. Shariat S.F., Godoy G., Lotan Y. et al. Advanced patient age is associated with inferior cancer-specific survival after radical nephroureterectomy. BJU Int 2010;105 (12):1672-7. DOI: 10.1111/j.1464-410X.2009.09072.x.

7. Soria F., Shariat S.F., Lerner S.P. et al. Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC). World J Urol 2017;35(3):379-87. DOI: 10.1007/s00345-016-1928-x.

8. Minaev V.P. Patent RUS № 2535454/10.12.2014. Bulletin No. 34. Method for biotissue incision by laser light and device for implementing it. Available at: http://www.freepatent.ru/images/img_patents/2/2535/2535454/patent-2535454.pdf. (In Russ.).

9. Teplov A.A., Grickevich A.A., Stepanova Yu.A. et al. Primary-multiple cancer of transitional epithelium: diagnostics and peculiarities of the disease. Eksperimental'naya i klinicheskaya urologiya = Experimental and Clinical Urology 2018;(4):22-9. (In Russ.).

10. Sadykov A.R., Dymov A.M., Enikeev N.N. et al. Tm fiber laser application for soft tissue surgery. In: Proceedings of the 17th International Conference “Laser Optics 2016”. Saint-Petersburg, 2016. P. 77.

11. A.G. Martov, D.V. Ergakov, N.A. Baykov et al. Transurethral en bloc resection of bladder tumors. Onkourologiya = Cancer Urology 2015;(1):41-9. (In Russ.).

12. Sylvester R.J., Brausi M.A., Kirkelsetal W.J. Long-term efficacy results of EORTC genito-urinary group randomized phase 3 study 30911 comparing intravesical instillations of epirubicin, bacillus Calmette-Guerin, and bacillus Calmette-Guerin plus isoniazid in patients with intermediate- and high-risk stage Ta T1 urothelial carcinoma of the bladder. Eur Urol 2010;57(5):766-73. DOI: 10.1016/j.eururo.2009.12.024.

13. Clinical guideline. Urothelial cancer of the upper urinary tract. Moscow: Ministry of Health of the Russian Federation, 2018. Рр. 11-13. (In Russ.).

14. Wu Y.P., Lin T.T., Chen S.H. et al. Comparison of the efficacy and feasibility of en bloc transurethral resection of bladder tumor versus conventional transurethral resection of bladder tumor: a meta-analysis. Medicine (Baltimore) 2016;95(45):e5372. DOI: 10.1097/MD.0000000000005372.

15. Sorokin N.I., Enikeev D.V., Dymov A.M. et al. Safety and efficacy of thulium transurethral en block resection with fiber laser “Urolaz” for treatment of non-muscle-invasive bladder cancer. Onkourologiya = Cancer Urology 2018; 14(1):144-51. (In Russ.).

16. Vinarov A.Z., Dymov A.M., Sorokin N.I. et al. Laser hydrodynamic biotissue dissection in operative urology. Andrologiyai genital'naya khirurgiya = Andrology and Genital Surgery 2018;19(2):21-30. (In Russ.).


Review

For citations:


Novikov M.E., Meleshko N.A., Akopyan I.G. Tulium laser in urothelial carcinoma of the bladder with spread to the ostium of the ureter. Cancer Urology. 2020;16(3):198-204. (In Russ.) https://doi.org/10.17650/1726-9776-2020-16-3-198-204

Views: 768


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1726-9776 (Print)
ISSN 1996-1812 (Online)
X